Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

B. Escudier1, C. Porta2, M. Schmidinger3, F. Algaba4, J. J. Patard5, V. Khoo6,7, T. Eisen8 & A. Horwich6 on behalf of the ESMO Guidelines Working Group* Institut Gustave Roussy, Villejuif, France; IRCCS San Matteo University Hospital Foundation, Pavia, Italy; Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Pathology, Fundació Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain; CHU Bicêtre, Université Paris XI, Kremlin Bicêtre, France; Institute of Cancer Research and Royal Marsden Hospital, London, UK; Monash University, Melbourne, Australia; Cambridge Biomedical Campus, Cambridge, UK